|
1
|
Ferlay J, Ervik M, Dikshit R, Eser S,
Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: IARC CancerBase No. 11.
|
|
2
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mohammed ME, Hassan AM, Abdelhadi HA,
Elsadig MG, Adam DM, Elmamoun K, Hamid R, Elias H, Abdallah M,
Abdelkarim Z, Elwali NE and Mohammed SI: Burden and pattern of
cancer in the Sudan, 2000–2006. Br J Med Med Res:. 4:1231–1243.
2014. View Article : Google Scholar
|
|
4
|
Saeed IE, Weng HY, Mohamed KH and Mohammed
SI: Cancer incidence in Khartoum, Sudan: First results from the
cancer registry, 2009–2010. Cancer Med. 3:1075–1084. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Holschneider CH and Berek JS: Ovarian
cancer: Epidemiology, biology, and prognostic factors. Semin Surg
Oncol. 19:3–10. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Greene FL, Page DL, Fleming ID, Fritz A,
Balch CM, Haller DG and Morrow M: American Joint Committee on
Cancer: AJCC Cancer Staging Manual. 6th. Springer; New York, NY:
pp. 157–164. 2002
|
|
8
|
Shepherd JH: Revised FIGO staging for
gynaecological cancer. Br J Obstet Gynaecol. 96:889–892. 1989.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fritz AG: International classification of
diseases for oncology: ICD-O. World Health Organization. 2000.
|
|
10
|
Naing NN: Easy way to learn
standardization: direct and indirect methods. Malays J Med Sci.
7:10–5. 2000.PubMed/NCBI
|
|
11
|
Morgan RJJ, Alvarez RD, Armstrong DK, et
al: NCCN clinical practice guidelines in oncology: epithelial
ovarian cancer. J Natl Compr Cancer Netw. 9:82–113. 2011.
|
|
12
|
Vanderpuye V and Yarney J: Ovarian cancer:
An analysis of forty-four patients at the national radiotherapy
centre, Accra-Ghana. West Afr J Med. 26:93–96. 2007.PubMed/NCBI
|
|
13
|
Rabiu KA, Akinola OI, Adewunmi AA, Fabamwo
AO, Adedeji MO and Popoola AO: Delays in presentation and
management of ovarian cancer in Lagos, Nigeria. J Obstet Gynaecol.
33:305–308. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Doh AS and Shasha W: A
clinico-pathological study of ovarian tumors in Yaounde-Cameroun.
West Afr J Med. 13:196–199. 1994.PubMed/NCBI
|
|
15
|
Basu P, De P, Mandal S, Ray K and Biswas
J: Study of ‘patterns of care’ of ovarian cancer patients in a
specialized cancer institute in Kolkata, eastern India. Indian J
Cancer. 46:28–33. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Quirk JT and Natarajan N: Ovarian cancer
incidence in the United States, 1992–1999. Gynecol Oncol.
97:519–523. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
van Altena AM, Karim-Kos HE, de Vries E,
Kruitwagen RF, Massuger LF and Kiemeney LA: Trends in therapy and
survival of advanced stage epithelial ovarian cancer patients in
the Netherlands. Gynecol Oncol. 125:649–654. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Harford JB: Breast-cancer early detection
in low-income and middle-income countries: Do what you can versus
one size fits all. Lancet Oncol. 12:306–312. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gharoro EP and Eirewele O: Cancer of the
ovary at the university of benin teaching hospital: A 10-year
review, 1992–2001. Afr J Med Med Sci. 35:143–147. 2006.PubMed/NCBI
|
|
20
|
Sankaranarayanan R and Ferlay J: Worldwide
burden of gynaecological cancer: The size of the problem. Best
Pract Res Clin Obstet Gynaecol. 20:207–225. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bray F, Loos AH, Tognazzo S and La Vecchia
C: Ovarian cancer in Europe: Cross-sectional trends in incidence
and mortality in 28 countries, 1953–2000. Int J Cancer.
113:977–990. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Morris CR, Rodriguez AO, Epstein J and
Cress RD: Declining trends of epithelial ovarian cancer in
California. Gynecol Oncol. 108:207–213. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lowe KA, Chia VM, Taylor A, O'Malley C,
Kelsh M, Mohamed M, Mowat FS and Goff B: An international
assessment of ovarian cancer incidence and mortality. Gynecol
Oncol. 130:107–114. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wong KH, Mang OW, Au KH and Law SC:
Incidence, mortality, and survival trends of ovarian cancer in Hong
Kong, 1997 to 2006: A population-based study. Hong Kong Med J.
18:466–474. 2012.PubMed/NCBI
|
|
25
|
Ahmad OBB-PC, Lopez AD, Murray CJL, Lozano
R and Inoue M: Age standardization of rates: A new WHO
standardGlobal programme on evidence for health policy discussion
paper Series: no. 31. Geneva: 2000
|
|
26
|
Bray F, Guilloux A, Sankila R and Parkin
DM: Practical implications of imposing a new world standard
population. Cancer Causes Control. 13:175–182. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bray F, Ren JS, Masuyer E and Ferlay J:
Global estimates of cancer prevalence for 27 sites in the adult
population in 2008. Int J Cancer. 132:1133–1145. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bristow RE, Tomacruz RS, Armstrong DK,
Trimble EL and Montz F: Survival effect of maximal cytoreductive
surgery for advanced ovarian carcinoma during the platinum era: A
meta-analysis. J Clin Oncol. 20:1248–1259. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Adekanbi AA, Olayemi O, Okolo CA, Fawole
AO, Odukogbe AT and Okani CO: Survival of ovarian cancer patients
in Ibadan: Clinical and pathological factors. J Obstet Gynaecol.
34:57–59. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sankaranarayanan R, Black RJ, Swaminathan
R and Parkin DM: An overview of cancer survival in developing
countries. IARC Sci Publ. 135–157. 1998.PubMed/NCBI
|
|
31
|
Tangjitgamol S, Manusirivithaya S,
Laopaiboon M, Lumbiganon P and Bryant A: Interval debulking surgery
for advanced epithelial ovarian cancer. Cochrane Database Syst Rev:
CD006014. 2016. View Article : Google Scholar
|
|
32
|
Bristow RE, Eisenhauer EL, Santillan A and
Chi DS: Delaying the primary surgical effort for advanced ovarian
cancer: A systematic review of neoadjuvant chemotherapy and
interval cytoreduction. Gynecol Oncol. 104:480–490. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Iyoke C, Ugwu G, Ezugwu E, Onah N, Ugwu O
and Okafor O: Incidence, pattern and management of ovarian cancer
at a tertiary medical center in Enugu, South East Nigeria. Ann Med
Health Sci Res. 3:417–421. 2013. View Article : Google Scholar : PubMed/NCBI
|
